Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overview
Explore Anbio Biotechnology Class A Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.
Anbio Biotechnology Class A Ordinary Shares (NNNN)
Key Financials
Key Financials
Market Cap
709.3M
P/E Ratio
99.66
EPS (TTM)
$0.15
ROE
0.23%
NNNN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Anbio Biotechnology Class A Ordinary Shares (NNNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 26.91, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $53.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 99.66 and a market capitalization of 709.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.